Vascular endothelial growth factor gene insertion/deletion polymorphism is associated with Vitamin D level in Turkish patients with coronavirus disease 2019

Rev Assoc Med Bras (1992). 2023 Jul 17;69(7):e20221713. doi: 10.1590/1806-9282.20221713. eCollection 2023.

Abstract

Objective: Coronavirus disease 2019 emerges as a disease caused by severe acute respiratory syndrome coronavirus 2. It is a systemic disease associated with vascular inflammation and endothelial damage. In this study, we aimed to investigate whether vascular endothelial growth factor gene insertion/deletion polymorphism is associated with coronavirus disease 2019 in the Turkish population.

Methods: The study included 179 participants (79 patients with coronavirus disease 2019 and 100 controls). DNA isolation was made from peripheral blood, and then the polymerase chain reaction analysis was performed.

Results: When we analyze vascular endothelial growth factor gene insertion/deletion polymorphism in the study group, we found that the DD genotype and D allele were found to be statistically significantly different when compared to coronavirus disease 2019 patients with high vitamin D value (p=0.005 for DD genotype and p=0.006 for D allele) in the control group. In this high-level control group, when we analyze II+ID genotype versus DD, a statistically significant difference was also detected (p=0.007).

Conclusion: As a result of the study, we found that DD genotype and D allele were associated with vitamin D level in Turkish patients with coronavirus disease 2019.

MeSH terms

  • COVID-19* / genetics
  • Genotype
  • Humans
  • Mutagenesis, Insertional
  • Peptidyl-Dipeptidase A / genetics
  • Polymorphism, Genetic
  • Vascular Endothelial Growth Factor A* / genetics

Substances

  • Peptidyl-Dipeptidase A
  • Vascular Endothelial Growth Factor A
  • VEGFA protein, human